FDA NDC Directory · JSON-LD · Markdown

SEROQUEL XR

NDC 0310-0281 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic namequetiapine
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryNew Drug Application (innovator) · App NDA022047
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsQUETIAPINE FUMARATE (150 mg/1)
Marketing started20090201
Marketing ended20270630
Package count1

External sources

Source: openFDA. Public-domain (CC0).